Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup Analyses. - Cherney DZI; Rossing P; Canziani ME; Caramori ML; Correa-Rotter R; Cronin L; Hugo C; Ji B; Meyerhoff J; Nangaku M; Silva A; Urbach D; et al. (Diabetes, obesity & metabolism, 2026)